Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to
Angelini Pharma secures exclusive global license rights to future identified drug targets
Quiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and royalties
Collaboration further expands Angelini Pharma’s focus on brain health, building on its deep therapeutic expertise and drug development experience
Quiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and royalties
Collaboration further expands Angelini Pharma’s focus on brain health, building on its deep therapeutic expertise and drug development experience
本文链接：http://www.iruis.com/News/cninfo/75111.shtml
热门资讯
追觅创始人俞浩：今天将推出对标携程产品，打破垄…
佚名
点击：143
卡萨帝官宣与敦煌博物馆达成合作
佚名
点击：136
卡萨帝线下展冰吧新品，线上邀你当体验官
佚名
点击：120
行业唯一！海尔青岛净水互联工厂入选全球灯塔工厂
佚名
点击：120
海尔净水获工业4.0国际大奖，中国份额第一
佚名
点击：117
Meta 裁员 1000 人，战略重心从元宇宙转向人工智能…
佚名
点击：117
碳中和与用户是啥关系？看似很远，实则很近
佚名
点击：115
宜家、无印良品收缩战线，外资家居失宠了？
佚名
点击：113
从大厨房、大暖通到大家居，海尔智家打破行业边界
佚名
点击：112
消息称字节跳动正研发新一代豆包 AI 耳机
佚名
点击：111